Study design
This was an open-label, multi-center Phase 1/2a study (NCT02895360) conducted between August 2016 and August 2020; results from the completed Phase 2a portion of the study are reported here. The Independent Ethics Committees of the six study sites, and relevant authorities in Switzerland, approved the study protocol. All patients provided written informed consent prior to study participation.